Fingerprint
Dive into the research topics of 'Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
R Gniadecki, Knud Kragballe, Hans Thorhauge Dam, L Skov